Liam Wilson

The recent meeting of the Pulmonary-Allergy Drugs Advisory Committee concluded with a vote of 12-1 against the approval of gefapixant for the treatment of chronic cough. This decision is based on the current evidence, which suggests that the small reductions in cough frequency observed during phase III trials do not provide a clinically meaningful benefit
0 Comments
The once-glamorous world of Hollywood is grappling with the pressing need for redemption. After the strike that caused tumultuous setbacks for the industry, “fixes” are being ardently pursued. However, they must surpass mere cost-cutting measures and movie release delays that have already taken a toll. Studios such as Disney have witnessed the devastating loss of
0 Comments
Recent warnings about potentially high lead levels in recalled applesauce packets have put pediatricians on alert. While it is not yet clear if children exposed to these packets have experienced acute lead poisoning, experts advise taking the warnings seriously. According to Dr. Morri Markowitz, director of the Lead Poisoning Prevention and Treatment Program at the
0 Comments